Signifier Medical Technologies Limited

Founded in 2015 and based in Leicester, UK, Signifier Medical Technologies Ltd. , formerly known as Snoozeal Limited, operates as a medical technology company that develops therapies for sleep-disordered breathing. The company was founded by its CEO, Akhil Tripathi. In July 2021, Signifier Medical Technologies Ltd.

raised USD 35 million in Series D funding co-led by Segulah, Angelus Capital Group, and Pioneer Healthcare Partners, and in March 2022, Waha Capital, Angelus Capital Group, and Segulah acquired existing shares of other investors at Signifier Medical Technologies Limited. As of 2022, the company operates offices in London (UK), Needham (Massachusetts, USA), and Berlin (Germany). Signifier Medical develops and offers non-invasive solutions such as an anti-snoring device for people affected by mild obstructive sleep apnea to help them stop snoring long-term. The company’s portfolio includes an anti-snoring device called eXciteOSA® that works in conjunction with the company’s mobile application to monitor patients and report back to their physicians.

The company's device can cure snoring in patients if used once a day for 20 minutes. Its suite of products includes a control unit, a rechargeable unit that attaches to the mouthpiece through a mini-USB connection; a mouthpiece; a smartphone app that triggers electrodes in the mouthpiece that stimulate the tongue, and a remote that regulates or activates electrodes in the mouthpiece.